信德集團(00242.HK)約7.24億人幣沽珠海辦公室及零售單位予澳博(00880.HK)附屬
信德集團(00242.HK)公布,今日(28日)其間接全資附屬公司出售位於珠海之多個辦公室單位及一個零售單位,代價約為7.24億元人民幣。買方為澳博(00880.HK)的間接附屬公司SJM-投資有限公司。
物業涉及珠海橫琴新區的項目寫字樓第21層至29層及第31層至33層之分層辦公室單位,並商業裙樓第1層之一個零售單位。該等物業之總建築面積約為19,781平方米。目前該等物業處於空置狀態,自該項目立項以來並無產生任何租金收入。
集團預計將從出售事項錄得除稅前收益約7,350萬元人民幣,出售事項之銷售所得款項將用於補充集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.